{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:34:49Z","timestamp":1791153289792,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"21-22","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.vaccine.2004.01.049","type":"journal-article","created":{"date-parts":[[2004,2,23]],"date-time":"2004-02-23T20:14:16Z","timestamp":1077567256000},"page":"2722-2729","source":"Crossref","is-referenced-by-count":109,"title":["Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16\/18 E6E7)"],"prefix":"10.1016","volume":"22","author":[{"given":"E.J","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pawlita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.C","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hickling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C","family":"Kitchener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.L","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2004.01.049_BIB1","first-page":"393","article-title":"Vulval intraepithelial neoplasia: current perspectives","volume":"22","author":"Jones","year":"2001","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"5","key":"10.1016\/j.vaccine.2004.01.049_BIB2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1525-1438.2002.01140.x","article-title":"VIN 3: a clinicopathologic review","volume":"12","author":"McNally","year":"2002","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"11","key":"10.1016\/j.vaccine.2004.01.049_BIB3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1471-0528.1989.tb03234.x","article-title":"Vulval intraepithelial neoplasia\u2014management and outcome","volume":"96","author":"Shafi","year":"1989","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.01.049_BIB4","first-page":"192","article-title":"Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy","volume":"61","author":"Abdel-Hady","year":"2001","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.vaccine.2004.01.049_BIB5","first-page":"400","article-title":"Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women","volume":"63","author":"Davidson","year":"2003","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.vaccine.2004.01.049_BIB6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1074-7613(00)80101-6","article-title":"The makings of a tumour rejection antigen","volume":"11","author":"Gilboa","year":"1999","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.vaccine.2004.01.049_BIB7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/088282403322017866","article-title":"Cervical cancer vaccines: recent advances in HPV research","volume":"16","author":"Eiben","year":"2003","journal-title":"Viral Immunol."},{"issue":"16","key":"10.1016\/j.vaccine.2004.01.049_BIB8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0264-410X(96)00117-X","article-title":"Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer","volume":"14","author":"Boursnell","year":"1996","journal-title":"Vaccine"},{"issue":"9014","key":"10.1016\/j.vaccine.2004.01.049_BIB9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(96)90674-1","article-title":"A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer","volume":"347","author":"Borysiewicz","year":"1996","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2004.01.049_BIB10","first-page":"3676","article-title":"Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer","volume":"8","author":"Kaufmann","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"17-19","key":"10.1016\/j.vaccine.2004.01.049_BIB11","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0264-410X(00)00488-6","article-title":"Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer","volume":"19","author":"Adams","year":"2001","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2004.01.049_BIB12","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/S0264-410X(01)00086-X","article-title":"Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens","volume":"19","author":"van der Burg","year":"2001","journal-title":"Vaccine"},{"issue":"29-30","key":"10.1016\/j.vaccine.2004.01.049_BIB13","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/S0264-410X(02)00350-X","article-title":"Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine","volume":"20","author":"de Jong","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.01.049_BIB14","first-page":"6032","article-title":"Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16\/18 oncoproteins","volume":"63","author":"Davidson","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.vaccine.2004.01.049_BIB15","first-page":"5205","article-title":"Vaccinia-expressed human papillomavirus 16 and 18 E6 and E7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia","volume":"9","author":"Baldwin","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.vaccine.2004.01.049_BIB16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jcp.37.11.1201","article-title":"Vulvar intraepithelial neoplasia and microinvasive carcinoma of the vulva","volume":"37","author":"Buckley","year":"1984","journal-title":"J. Clin. Pathol."},{"issue":"1-2","key":"10.1016\/j.vaccine.2004.01.049_BIB17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-1759(01)00376-3","article-title":"Generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology","volume":"253","author":"Sehr","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.vaccine.2004.01.049_BIB18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-0934(02)00134-9","article-title":"HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase","volume":"106","author":"Sehr","year":"2002","journal-title":"J. Virol. Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2004.01.049_BIB19","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1099\/vir.0.19095-0","article-title":"Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia","volume":"84","author":"Davidson","year":"2003","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.vaccine.2004.01.049_BIB20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0264-410X(98)00146-7","article-title":"Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts","volume":"17","author":"Thompson","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2004.01.049_BIB21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/beog.2001.0220","article-title":"The role of human papillomavirus vaccines in cervical neoplasia","volume":"15","author":"Stern","year":"2001","journal-title":"Best Practice Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.vaccine.2004.01.049_BIB22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1999.tb01326.x","article-title":"Induction of CD8+ T-cells using heterologous prime-boost immunisation strategies","volume":"170","author":"Schneider","year":"1999","journal-title":"Immunol. Rev."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T01:28:22Z","timestamp":1550194102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":22,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0264410X04001197"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.01.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}